title: [Serotoninergic syndrome after combining tramadol and iproniazid].
authors.forename: A
authors.initials: A
authors.lastname: de Larquier
authors.forename: T
authors.initials: T
authors.lastname: Vial
authors.forename: G
authors.initials: G
authors.lastname: Bréjoux
authors.forename: J
authors.initials: J
authors.lastname: Descotes
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001416:Back Pain / Q000188:drug therapy; D004357:Drug Synergism; D006801:Humans; D006945:Hyperhidrosis / Q000139:chemically induced*; D007490:Iproniazid / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D009207:Myoclonus / Q000139:chemically induced*; D012021:Reflex, Abnormal / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced*; D014147:Tramadol / Q000008:administration & dosage / Q000009:adverse effects*; D014202:Tremor / Q000139:chemically induced
chemical_list: D000701:Analgesics, Opioid; D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D014147:Tramadol; D007490:Iproniazid